Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Breast Cancer Research and Treatment
Published in: Breast Cancer Research and Treatment 1/2002

01-07-2002

Semi-quantitative immunohistochemical analysis of aromatase expression in ductal carcinoma in situ of the breast

Authors: Zhenhuan Zhang, Hiroko Yamashita, Tatsuya Toyama, Yasuo Hara, Yoko Omoto, Hiroshi Sugiura, Shunzo Kobayashi, Nobuhiro Harada, Hirotaka Iwase

Published in: Breast Cancer Research and Treatment | Issue 1/2002

Login to get access
Metadata
Title
Semi-quantitative immunohistochemical analysis of aromatase expression in ductal carcinoma in situ of the breast
Authors
Zhenhuan Zhang
Hiroko Yamashita
Tatsuya Toyama
Yasuo Hara
Yoko Omoto
Hiroshi Sugiura
Shunzo Kobayashi
Nobuhiro Harada
Hirotaka Iwase
Publication date
01-07-2002
Publisher
Kluwer Academic Publishers
Published in
Breast Cancer Research and Treatment / Issue 1/2002
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1023/A:1016022314608

Other articles of this Issue 1/2002

Breast Cancer Research and Treatment 1/2002 Go to the issue

OriginalPaper

Delayed type hypersensitivity response to recall antigens does not accurately reflect immune competence in advanced stage breast cancer patients

OriginalPaper

GSTM1 and GSTT1 polymorphisms and postmenopausal breast cancer risk

OriginalPaper

Down-regulation of the CD3-ζ chain in sentinel node biopsies from breast cancer patients

OriginalPaper

Insulin-like growth factor binding proteins 1 and 3 and breast cancer outcomes

OriginalPaper

C-myc oncogene amplification in ductal carcinoma in situ of the breast

OriginalPaper

In vitro search for synergy and antagonism: evaluation of docetaxel combinations in breast cancer cell lines
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits